tiprankstipranks
Elicio Therapeutics (ELTX)
NASDAQ:ELTX

Elicio Therapeutics (ELTX) Financial Statements

185 Followers

Elicio Therapeutics Financial Overview

Elicio Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.793; its P/E ratio is -0.79; Elicio Therapeutics is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -11.21M$ -10.66M$ -6.84M$ -4.68M$ -6.84M
EBITDA$ -10.90M$ -10.39M-$ -4.64M$ -6.58M
Net Income Common Stockholders$ -11.83M$ -10.66M$ -7.56M$ -4.54M$ -6.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.90M$ 14.84M$ 21.68M$ 29.20M$ 50.50M
Total Assets$ 24.48M$ 30.99M$ 37.62M$ 41.75M$ 52.79M
Total Debt$ 6.67M$ 7.15M$ 7.40M$ 297.00K$ 3.71M
Net Debt$ -5.23M$ -7.69M$ -14.28M$ -28.90M$ -46.79M
Total Liabilities$ 19.61M$ 17.70M$ 14.06M$ 2.10M$ 9.02M
Stockholders Equity$ 4.87M$ 13.29M$ 23.56M$ 39.65M$ 43.77M
Cash Flow-
Free Cash Flow$ -12.12M$ -5.23M-$ -8.03M$ -4.43M
Operating Cash Flow$ -12.12M$ -5.18M$ -9.54M$ -8.03M$ -4.43M
Investing Cash Flow$ 3.00K$ -45.00K$ 10.01M$ -10.00M-
Financing Cash Flow$ 11.02M$ 59.00K$ 34.82M$ -3.27M$ -15.00K
Currency in USD

Elicio Therapeutics Earnings and Revenue History

Elicio Therapeutics Debt to Assets

Elicio Therapeutics Cash Flow

Elicio Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis